Publications

Refereed articles

1. Gibson KF, Widnell CC.  The relationship between laneller bodies and lysosomes in type II pneumocytes.  Amer J. Respir. Cell.Mol. Biol. 1991:4(6):504-513. PMID:2054192
2. Gibson KF.  Respiratory health of minorities: issues of access, race, and ethnicity.  Am. J. Respir. Crit. Care Med. 1994; 149:570-571. PMID:8118619
3. Gibson KF, Phadke S.  Intracellular localization of lysozyme in type II pneumocytes.  Exp. Lung Res. 1994; 20:595-611.    PMID:  7882908
4. Gibson KF, Aguayo S, Flowers JC, Ford JG, Jackson JJ, Roman J, Lwebuga-Mukasa JS, Samet J, Thomas AV, Young RC, Ram JS, Hurd SS.  Respiratory diseases disproportionately affecting minorities.  Chest 1995; Nov 108:1380-1392.  PMID: 7587446
5. Eurkhimov JA, Gibson KF, Yousem SA, Watkins SA, Wasserloos K, Lazo JS, Pitt BR.  Acetominophen-induced hepatic and pulmonary toxicity in metallothionein-I and –II nul mutant mice.  Am. J. Respir. Crit. Care Med. 1997.
6. Erukhimov JA, Tang Z, Johnson BA, Donahoe MP, Razzack JA, Gibson KF, Lee WM, Wasserloos KJ, Watkins SA, Pitt BR.  Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells.  Am. J. Respir. Crit. Care Med. 2000 Vol. 162 288-294.  PMID: 10903256
7. Zamora R, Vodovotz Y, Alarcon L, Betten B, Loughran PA, Aulak KS, Stuehr DJ, Gibson KF, Billiar TR.  Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.  Arch Biochem Biophys. 2001 Jun 15;390(2):287-94  PMID: 11396931
8. Zamora R, Alarcon L, Vodovotz Y, Betten B, Kim PK, Gibson KF, Billiar TR.  Nitric oxide suppresses the expression of Bcl-2 binding protein BNIP3 in hepatocytes.  J Biol Chem. 2001 Dec 14;276(50):46887-95. Epub 2001 Oct.    PMID: 11592958
9. Ameredes BT, Zamora R, Gibson KF, Billiar TR, Dixon-McCarthy B, Watkins S, Calhoun WJ. Increased nitric oxide production by airway cells of sensitized and challenged IL-10 knockout mice.   J Leukoc Biol. 2001 Nov;70(5):730-6  PMID: 11698492
10. Gibson K, Kaminski N.  Mechanisms of Pulmonary Fibrosis – Can we see the elephant?    Drug Discovery Today:  Disease Mechanisms, Oct 2004 Volume 1, Issue 1 117-122.
11. Dauber JH, Gibson KF, Kaminski N.  Interferon –γ-1B in Idiopathic Pulmonary Fibrosis.  What We Know and What Must We Learn.  Am J  Respir Crit Care Med 2004; 170(2): 107-108.  PMID:  15242850
12.  Perez A, Coxson HO, Hogg JC, Gibson K, Thompson PF, Rogers RM.   Use of CT morphometry to detect changes in lung weight and gas volume.  Chest. 2005 Oct;128(4):2471-7   PMID:16236911
13. Zamora R, Vodovota Y, Betten B, Wong C, Zuckerbraun B, Gibson KF, Ford HF.  Intestinal and Hepatic Expression of BNIP3 in Necrotizing Entercolitis:  Regulation by Nitric Oxide and Peroxynitrite.   Am J Physiol Gastrointest Liver Physiol 2005 Nov;289(5):G822-30. Epub 2005 Jul 7. PMID: 16002567
14. Gagermeier JP, Gibson KF, Dauber JH, Yousem SA, Fernando C, Kaminski N.   Endothelial Cell Phenotype in IPF Patients with Secondary Pulmonary Hypertension.  Chest 2005. Dec:128 (6 Suppl) 601S.
15. Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C,  Yousem S,  Herrera I,  Ruiz V,  Selman M, and Kaminski N+. Upregulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.  Public Library of Science Medicine 2005 Sept; Vol 2 Issue 9:e251.  PMID:  16128620; PMCID: PMC1198037
16. Feghali-Bostwick CA, Tsai CG, Valentine VG, Kantrow S,. Stoner MW, Pilewski JM, Gadgil A, George MP, Gibson KF, Choi AMK, Kaminski N, Zhang Y, and Duncan SR. Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis. J. Immunol. 2007, 179(4):2592-2599. PMID: 17675522
17. Rosas IO, Richards TJ, Konishi K,  Zhang Y, Gibson K, Lokshin AE, Lindell KO, Cisneros J, MacDonald S, Pardo A, Sciurba F, Dauber J, Selman M, Gochuico BR, Kaminski N.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis.  2008 PLoS Med  5(4):e93.  PMID:  18447576; PMCID: PMC2346504
18. Vuga L, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson K, Feghali-Bostwick C, Kaminski N.  WNT5A is increased in Usual Interstitial Pneumonia Fibroblasts and is an Inducer of Fibroblast Proliferation and Survival.  Am J Respir Cell Mol Biol 2009 Nov;41(5):583-9. doi: 10.1165/rcmb.2008-0201OC. Epub 2009 Feb 27.  PMID: 19251946; PMCID: PMC2778165
19. Richards TJ ,  Eggebeen A,  Gibson K,  Yousem S, Fuhrman S, Gochuico BR, Fertig N, Oddis CV,  Kaminski N, Rosas IO, Ascherman DP.  Characterization and Peripheral Blood Biomarker Assessment of Jo-1 Antibody-Positive Interstitial Lung Disease.  Arthritis and Rheumatism  2009 Jul;60(7):2183-2192. PMID: 19565490; PMCID: PMC2710404
20. Konishi K , Gibson K, Lindell K, Richards T, Zhang Y, Dhir R, Biceglia M, Yousem S,  Gilbert S, Song JW, Kim DS, Kaminski, N.   Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2009 Jul 15;180(2):167-75.  PMID: 19363140; PMCID: PMC2714820
21. Choi, J, Hoffman LA, Sethi, JM, Zullo T, Gibson KF.  Multiple Flow Rates Measurement of Exhaled Nitric Oxygen Patients with Sarcoidosis:  A Pilot Feasibility Study.Sarcoidosis Vasculitie and Diffuse Lung Diseases 2009 Jul; 26(2):98-109. PMID: 20560290; PMCID: PMC2889917
22. Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, Valentine VG, Lindsay EK, George MP, Steele C, Duncan SR.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.  PLoS One. 2010 Jan 29;5(1):e8959.  PMID: 20126467; PMCID: PMC2813297
23. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The Pulmonary Histopathologic Manifestations of the anti-Jo-1 tRNA Synthetase Syndrome.  Modern Pathology 2010 2010 Jun; 23(6):874-80. PMID:20228783
24. Pandit KV,  Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Kazuhisa K, Yousem S, Singh M,  Handley D,  Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O,  Ray P, Benos PV, Kaminski N. Inhibition and role of let-7d in Idiopathic Pulmonary Fibrosis., Am J Respir Crit Care Med. 2010 Jul 15:182(2):220-9. Epub 2010 Apr 15.  PMID: 20395557; PMCID: PMC2913236
25. Lindell KO, Olshansky E, Song MK, Zullo T, Gibson K, Kaminski N, Hoffman L.  Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.  Heart & Lung June 2010 Vol. 39 No. 4 July/August 2010. PMID: 20561836; PMCID: PMC3467095
26. Xue J, Gochuico BR, Alawad AS, Feghali-Bostwick CA, Noth I, Nathan S, Rosen GD, Rosas IO, Dacic, S, Ocak I, Furhrman CR, Cuenco, KT, Smith MA, Jacobs SS, Zeevi A, Morel P, Pilewski JM, Valentine VG, Gibson KF, Kaminski N, Sciurba FC, Zhang Y, Duncan SR.  The HLA Class II Allele DRB1*1501 is Over-represented in Patients with Idiopathic Pulmonary Fibrosis. PLoS One. 2011 Feb 23;6(2):e14715. PMID: 21373184   PMCID: PMC3044131
27. Lindell  KO, Kaminski N, Gibson KF, Lareau S, Fahy B, & Swigris JJ. (2011) ATS Patient Information Series: Idiopathic Pulmonary Fibrosis (IPF), American Journal of Respiratory and Critical Care Medicine, (183) 687.
28. Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF  Peripheral blood proteins predict mortality in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2012; 185:67-76.   PMID: 22016448   PMCID: PMC3262037
29. Noth I, Gibson KF, Drake WP.  Where Next for Gene Expression Profiling? So Much Promise.  Am J Respir Crit Care Med 2011 Nov 15;184(10)1102-3.  PMID: 22086986
30. Schneider F, Hwang DM, Gibson K, Yousem SA. Non-Specific Interstitial Pneumonia (NSIP): A Study of Six Patients with Progressive Disease.  American Journal of Surgical Pathology 2012 Jan 12;36(1):89-93.  PMID: 22173118
31. Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF,  Pandit KV, Yu G, Yakhini Z, Kaminski N+. Global  Methylation Patterns in Idiopathic Pulmonary Fibrosis, PLoS One 2012;7(4):e33770. Epub 2012 Apr 10. PMID:  22506007  PMCID:  PMC3323629
32. Richards TJ, Park C, Chen Y, Gibson KF, Di YP, Pardo A, Watkins SC, Choi AM, Selman M, Pilewski J, Kaminski N, Zhang Y. Allele Specific Transactivation of Matrix Metalloproteinase 7 by FOXA2 and Correlation with Plasma Levels in Idiopathic Pulmonary Fibrosis   Am J Physiol Lung Cell and Mol Physiol 2012 Apr 15;302(8):L746-54. Epub 2012 Jan 20.   PMID:  22268124  PMCID:   PMC3331579
33. Richards TJ, Kaminski N., Gibson K. Plasma proteins for risk prediction in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012 Jun 15;185(12):1329-30. PMID:22707740
34. Baughman RP, Lower EE, Gibson K.  Pulmonary manifestations of sarcoidosis, Presse Med. 2012 Jun;41(6 Pt 2):e289-302. Epub 2012 May 10. PMID:22579234
35. Yu G, Kovkarova-Naumovski E, Jara P, Parwani A, Kass D, Ruiz V, Lopez-Otín C, Rosas IO, Gibson KF, Cabrera S, Ramírez R, Yousem SA, Richards TJ, Chensny LJ, Selman M, Kaminski N, Pardo A. Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.  Am J Respir Crit Care Med. 2012 Oct 15;186(8):752-62. doi: 10.1164/rccm.201202-0302OC. Epub 2012 Aug 2.  PMID:  22859522
36. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, Macmillan M, Kahn M, Kaminski N.  Profibrotic Role of miR-154 in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2012 Dec;47(6):879-87. doi: 10.1165/rcmb.2011-0377OC. Epub 2012 Oct 4. PMID:23043088; PMCID: PMC3547095
37. Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, Bon J, Soejima M, Levesque MC, Lindell KO, Gibson KF, Kaminski N, Banga G, Oddis CV, Pilewski JM, Sciurba FC, Donahoe M, Zhang Y, Duncan SR. Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.  Am J Respir Crit Care Med. 2013 Apr 1;187(7):768-75. doi: 10.1164/rccm.201203-0506OC. PMID:23262513;  PMCID:PMC3678112  Available on 2014/4/1]
38. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Cogan JD, Mason WR, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Smith K, McKean D, Pedersen BS, Talbert J, Kidd RN, Markin CR, Beckman KB, Lathrop M, Schwarz MI, Schwartz DA. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.  Nat Genet. 2013 Jun;45(6):613-20. doi: 10.1038/ng.2609. Epub 2013 Apr 14. PMID:  23583980; PMCID: PMC3677861
39. Peljto AL, Zhang Y, Fingerlin, TE, Ma SF, Garcia J, Richards TJ, Silveiri LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwartz MI, Kaminski N, Schwartz DA.   Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.  JAMA. 2013 Jun 5;309(21):2232-9. doi: 10.1001/jama.2013.5827.  PMID: 23695349 
40. Xue J, Kass DJ, Bon J, Vuga L, Tan J, Csizmadia E, Otterbein L, Soejima M, Levesque MC, Gibson KF, Kaminski N, Pilewski JM, Donahoe M, Sciurba FC, Duncan SR.   Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients.  J Immunol. 2013 Sep 1;191(5):2089-95. doi: 10.4049/jimmunol.1203476. Epub 2013 Jul 19.  PMID:23872052   PMCID:  PMC3804013
41. Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, Feingold E, Juan-Guardela BM, Richards TJ, Lussier Y, Huang Y, Vij R, Lindell KO, Xue J, Gibson KF, Shapiro SD, Garcia JG, Kaminski N.  Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis. Sci Transl Med. 2013 Oct 2;5(205):205ra136. PMID: 24089408
42. Vuga LJ, Milosevic J, Pandit K, Ben-Yehudah A, Chu Y, Richards T, Sciurba J, Myerburg M, Zhang Y, Parwani AV, Gibson KF, Kaminski N. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS One. 2013 Dec 20;8(12):e83120. doi: 10.1371/journal.pone.0083120.  PMID:  24376648 PMCID: PMC3869779
43. Vuga LJ1, Tedrow JR, Pandit KV, Tan J, Kass DJ, Xue J, Chandra D, Leader JK, Gibson KF, Kaminski N, Sciurba FC, Duncan SR.  C-X-C Motif Chemokine 13 (CXCL13) is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis.  Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC. PMID:24628285[PubMed - indexed for MEDLINE]    PMCID:PMC4098096[Available on 2015/4/15]
44. Baughman RP, Culver DA, Cordova FC, Padilla M, Gibson KF, Lower EE, Engel PJ.   Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.  Chest. 2014 Apr;145(4):810-7. doi: 10.1378/chest.13-1766. PMID:24177203[PubMed - indexed for MEDLINE]
45. Chien JW, Richards TJ, Gibson KF, Zhang Y, Lindell KO, Shao L, Lyman SK, Adamkewicz JI, Smith V, Kaminski N, O'Riordan T. Serum lysyl oxidase like-2 levels and idiopathic pulmonary fibrosis disease progression.  Eur Respir J. 2014 May;43(5):1430-8. doi: 10.1183/09031936.00141013. Epub 2013 Oct 31.  PMID: 24177001 [PubMed - in process]
46. Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.  Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.  J Clin Pathol. 2014 Aug;67(8):678-83. doi: 10.1136/jclinpath-2014-202367. Epub 2014 Jun 2. PMID:24891607[PubMed - in process]
47. Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES.  Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.  Eur Respir J. 2014 Jul 17. pii: erj00009-2014. [Epub ahead of print].  PMID:25034562[PubMed - as supplied by publisher]
48. Lindell KO, Liang Z, Hoffman LA, Rosenzweig MQ, Saul MI, Pilewski JM, Gibson KF, Kaminski N.  Palliative Care and Location of Death in Decedents with Idiopathic Pulmonary Fibrosis.  Chest. 2014 Sep 4. doi: 10.1378/chest.14-1127. [Epub ahead of print] PMID:25187973
49. Bauer Y1, Tedrow J, de Bernard S, Birker-Robaczewska M, Gibson KF, Juan Guardela B, Hess P, Klenk A, Lindell KO, Poirey S, Renault B, Rey M, Weber E, Nayler O, Kaminski N. A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis.  Am J Respir Cell Mol Biol. 2014 Jul 16. [Epub ahead of print]  PMID:25029475[PubMed - as supplied by publisher]

Book Chapters

1. Lindell, K.O., Gibson, K.F., & Champion, H.C. (2012). Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Pulmonary Hypertension. Integrative Therapies in Lung Health and Sleep. New York: Springer.

Published Abstracts

1. Gibson KF, Kitson RP, Widnell CC.  Internalization of antigen-antibody complexes for the surface of rat fibroblasts: Evidence for stable endosomes.  J. Cell Biol.; 103:216a.
2. Gibson KF, Widnell CC.  Functional characterization of rat type II cells in culture,  J. Cell Biol. 1988; 107(6):575a.
3. Gibson KF, Singh G, Widnell CC.  Surfactant apoprotein synthesis and secretion in cultured alveolar type II epithelial cells.  Am. Rev. Respir. Dis. 1989; 139(4):A576
4. Gibson KF, Singh G, Katyal S, Widnell CC.  The relationship between lysosomes and lamellar bodies in alveolar type II pneumocytes.  Am. Rev. Respir. Dis. 1990; 141(4):A102.\
5. Gibson KF, Widnell CC.  Characterization of a lamellar body fraction that is free of lysosomal constituents.  Am. Rev. Respir. Dis. 1991; 143(6):1473.
6. Albanese SA, Gibson KF, Widnell CC.  Uptake of endocytic markers by rat alveolar type II cells in culture.  J. Cell Biol. 1990; 111:188a.
7. Phadke S, Gibson KF, Widnell CC.  The subcellular localization of Lysozyme in rat type II epithelial cells.  J. Cell Biol. 1991; 115(3):303a.
8. Gibson KF, Widnell CC.  Uptake of fluorescent lipid analogues by rat type II pneumocytes in primary culture.  FASEB 1992; 6(4) part 1:a1162.
9. Gibson KF, Widnell CC.  Phospholipid uptake and metabolism by alveolar type II cells in primary culture.  Am. J. Respir. Crit. Care Med. 1994; 149(4):A92.
10. Gibson KF, Gross R, Thompson R, Viti C.  Hyperoxic-induced alveolar type II cell activation and hyperplasia in rodents.  Am. J. Respir. Crit. Care Med. 1995; 151:A181.
11. Green JW, Gibson KF, Schwartz MA, Lazo JS, Pitt BR.  Hypoxia fails to protect metallothionien null mice against hyperoxia lung injury.  Am. J. Respir. Crit. Care Med. 1996; 153:A736.
12. Erkhimov JA, Gibson KF, Yousem SA, Watkins SA, Wasserloos K, Lazo JS, Pitt BR.  Acetominophen-induced hepatic and pulmonary toxicity in metallothionein-I and –II nul mutant mice.  Am. J. Respir. Crit. Care Med. 1997.
13. Alarcon LH, Billiard TR, Gibson KF.  Hyperoxia-induced changes in gene expression in the lung detected by differential display.  Am. J. Respir. Crit. Care Med. 1997.
14. Alarcon LH, Hicks SA, Betten B, Gibson KF.  Upregulation of keratinocyte growth factor in hyperoxic lung injury.  Am. J. Respir. Crit. Care Med. 1998.
15. Alarcon LH, Hicks SA, Betten BL, Gibson KF.  Upregulation of keratinocyte growth factor recepto in hyperoxic lung injury.  Am. J. Respir. Crit Care Med. 1997; 157:A352.
16. Alarcon LH, Betten BL, Billiar TR, Simmons R, Gibson KF.  Hyperoxia induces the expression of plasminogen activator inhibitor-1 and novel genes in the lung.  Presentation at the Experimental Biology Meetings.  FASEB J. 1997; 12:A337.
17. Alarcon LH, Gibson KF, Simmons R, Billiam TR.  Nitric oxide induces the expression of novel genes in hepatocytes as detected by differential display-PCR.  Alimentary 1997.
18. Erukhimov JA, Donahoe MP, Watkins SA, Wasserloos KJ, Gibson KF, Pitt BR.  Gelsolin decreases toxicity of plasma from the patients with ARDS to the pulmonary artery endothelial cells.  Am. J. Respir. Crit. Care Med. 1997; 157:A679.
19. Alarcon LH, Hicks SP, Betten BL, Gibson KF. Upregulation of keratinocyte growth factor receptor in hyperoxic lung injury.   Am. J. Respir. Crit. Care Med. 1998: 157 (3): A352
20. Ameredes B, Zamora R, Gibson KF, Billiar TR, Dixon-McCarthy B, Calhoun W.  Nitric Oxide (NO) production by airway immune cells in sensitized and airway challenged IL-10ko mice. Am. J. Respir. Crit. Care Med.161 (3): A920, 2000.
21. Zhang Y, Yousem, S. Watkins, Kaminski N, Gibson KF.  Localization of Gene Expression in IPF Using Laser Capture Microdissection Am. J. Respir. Crit. Care Med  2003;167(7) A989
22. Lindell, KO, Hoffman, LA, Tasota FJ, Gibson KF, Dauber, JH.  Patient and Clinician Ratings of Anxiety and Depression:  How well do they Match?   American Journal of Respiratory and Critical Care Medicine 2004;169(7)  A726 Poster presented at ATS 2004 100th International Conference, Orlando, Florida, May, 2004.
23. Lindell, KO, Hoffman, LA, Tasota FJ, Gibson KF, Dauber, JH.  Patient and Clinician Ratings of Anxiety and Depression:  How well do they Match?   American Journal of Respiratory and Critical Care Medicine 2004;169(7)  A398.  Poster presented at ATS 2004 100th International Conference, Orlando, Florida, May, 2004.
24. Richards TJ, Day RS, Chensny LJ, Loutaev I, Fernando C, Gibson KF, Kaminski N.  Weakest Link Models for Microarray Data in Idiopathic Pulmonary Fibrosis.  Lindell, KO, Hoffman, LA, Tasota FJ, Gibson KF, Dauber, JH.  Patient and Clinician Ratings of Anxiety and Depression:  How well do they Match?   American Journal of Respiratory and Critical Care Medicine 2004;169(7)  A776 Poster presented at ATS 2004 100th International Conference, Orlando, Florida, May, 2004.
25. Gagermeier J, Dauber J, Gibson K, Richards T, Kaminski N.  Prevalence of Secondary Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis.   American Journal of Respiratory and Critical Care Medicine 2005;Volume 2 Abstracts Issue A205  Poster presented at ATS 2005 International Conference,  San Diego, CA, May, 2005.
26. Kovkarova-Naumovski K, Gibson K, Gagermeier J, Yousem S, Chensny L, Dauber J, Kaminski, N.   Microarray Analysis of Laser Capture Dissected Epithelial Cells from Patients with IPF. American Journal of Respiratory and Critical Care Medicine 2005;Volume 2 Abstracts Issue A242  Poster presented at ATS 2005 International Conference,  San Diego, CA, May, 2005.
27. Bower L, Dauber JH, Gibson KF, Kaminski N, Lindell, KO.  Patterns of Oxygen Use in Patients with Idiopathic Pulmonary Fibrosis (IPF) American Journal of Respiratory and Critical Care Medicine 2005;Volume 2 Abstracts Issue A388.  Poster presented at ATS 2005 International Conference,  San Diego, CA, May, 2005.
28. Jin Y, Wang L, Cummings S, Goldby-Reffner KA, Kaminski N,  Dauber JH, Choi AMK,  Gibson KF,  Zhang Y.  Evaluation of the CTGF Promoter Polymorphisms in Patients with Idiopathic Pulmonary Fibrosis.   American Journal of Respiratory and Critical Care Medicine 2005 Volume 2 Abstracts Issue A635.  Poster presented at ATS 2005 International Conference, San Diego, CA, May, 2005.
29. Gagermeier J, Dauber J, Yousem S Gibson K, Kaminski N.  Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension.  Chest 2005 Dec;128(6Suppl):601S.
30. Richards T, Gibson K, MD, Pardo A,  Lindell K,  Zhang Y, Lokshin A, Selman M, Dauber J,  Kaminski N.   Surrogate Protein Markers in the Blood of IPF Patients  Disease and Treatment Effects Am J  Respir Crit Care Med 2006 Volume 3 Abstracts Issue A799
31. Kovkarova-Naumovski E, Pardo A,  Morse D, Selman M, Richards T, Zhang Y, Gibson K, Kaminski N.  MMP19 Expression in Laser Capture Microdissected Epithelial Cells in IPF.  Am J  Respir Crit Care Med 2006 Volume 3 Abstracts Issue A767
32. Loutaev I, Reynolds P, Gibson K, Chensny L, Kaminski N.  Proteomic Analysis of IPF Lungs and Correlation with Microarray Data.  Am J  Respir Crit Care Med 2006 Volume 3 Abstracts Issue A308
33. Lindell, KO, Hoffman, LH, Zullo TJ, Olshansky E, Gibson, KF, Kaminski N.  Palliative Care in Patients with Idiopathic Pulmonary Fibrosis and Their Care Partners.  Am J Respir Crit Care Med 2007; 175: A242 Abstracts Issue April 2007.
34. Chin SA, Richards T, Zhang Y, Kaminski N, Gibson K.  Cytokine Profiling as a Marker of Disease Activity in Pulmonary Sarcoidosis.  Am J Respir Crit Care Med 2007; 175: A362 Abstracts Issue April 2007.
35. Konishi K, Richards T, Lindell, K, Chensny, L, Yu G, Herazo J, Gibson K, Kaminski N.  Gene expression profiles of Acute Exacerbations in Idiopathic Pulmonary Fibrosis Am J Respir Crit Care Med 2008; 177: A43, Abstracts Issue April 2008
36. Rosas IO, Weissfeld JL, Furman C, Gibson K, Leader JK, Gur D, Tedrow J, Kaminski N, Sciurba F.   Early Interstitial Lung Disease in Smokers from the PLuSS Study Am J Respir Crit Care Med 179;2009:A1125.
37. Herazo J, Juan B, Chensny L, Richards T, Konishi K,  LeJeune M, Ravinovich E,  Lindell  K,  Gibson K,  Kaminski N.  Gene Expression Patterns of Peripheral Blood Mononuclear Cells in Patients with Idiopathic Pulmonary Fibrosis.  Am J Respir Crit Care Med 179;2009:A2731
38. Konishi K, Gibson KF, Richards TJ, Lindell KO, Chensny LJ, Zhang Y,  Kaminski N,  Kim DS.  Expression of Alpha-Defensins in the Lungs and Peripheral Blood of Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.  Am J Respir Crit Care Med 179;2009:A3020.
39. Vuga LJ, Ben-Yehudah A, Pandit K, Zheng Y,  Sciurba J, Milosevic J, Chensny LJ, Konishi K,  Gibson KF,  Kaminski N. Cartilage Oligomeric Matrix Protein Is a Potential Biomarker for Idiopathic Pulmonary Fibrosis.    Am J Respir Crit Care Med 179;2009:A3487
40. Richards TJ, Lindell KO, Klesen M, Kaminski N, Zhang Y, Gibson KF. Peripheral Blood Biomarkers Predict Disease Progression And Mortality In IPF.  Am J. Respir Crit Care Med  May 2010; 181: A1120
41. Lindell KO, Hoffman K, Black TR, Richards TJ, Choi, J, Saul M, Kaminski N,  Gibson KF.  Extent And Impact Of Pulmonary Fibrosis In A Regional Health System Am J Respir Crit Care Med. May 2010; 181: A2966.
42. Kuhlengel T, Bascom R, Qian Z, Kaminski N, Lindell KO, Tino G, Criner GJ, Simonelli FC, Cordova FC, Patel N, Gibson KF.  Ambient Air Pollution Exposure of Patients in the Pennsylvania Idiopathic Pulmonary Fibrosis (PA-IPF) State Registry. Am J Respir Crit Care Med. May 2010; 181: A4618.
43. Zhang Y, Noth I, Gibson KF,  Ma SF, Richards TJ, Bon JM, Lindell KO, Branch RA, Nicolae D, Sciurba F, Garcia AN, and Kaminski N.  A Variant In The Promoter Of MUC5B Is Associated With Idiopathic Pulmonary Fibrosis And Not Chronic Obstructive Pulmonary Disease.  Am. J. Respir. Crit. Care Med., May 2011; 183: A6395.
44. Herazo JD, Gibson KF, Juan Guardela B,  Ma SF, Richards T, Lussier YA, Duncan SR, Tseng G, Lindell KO, Garcia JG, Noth I, and Kaminski N.  Peripheral Blood Monuclear Cells Gene Expression Patterns Predict Mortality In Patients With Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med., May 2011; 183: A5306.
45. Rakova I, Kapetanaki M, Pandit K, Chensny L, Gibson K, Ghedin E, and Kaminski N.  High-Throughput Sequencing Of MicroRNA In Idiopathic Pulmonary Fibrosis.  Am. J. Respir. Crit. Care Med., May 2011; 183: A5538.
46. Xue J, Gochuico BR, Feghali-Bostwick CA, Noth I, Nathan SD, Rosen G, Rosas IO, Gibson KF, Kaminski N, Sciurba FC, Zhang Y, and Duncan SR.  The HLA Class II Allele DRB1*1501 Is Over-Represented In Patients With Idiopathic Pulmonary Fibrosis.  Am. J. Respir. Crit. Care Med., May 2011; 183: A4272
47. Xue J, Kahloon RA, Bhargava A, Banga G, Gochuico BR, Dacic S,. Gibson KF, Kaminski N,  Sciurba FC, Rosas IO, Otterbein L, Zhang Y, and Duncan SR.  Decreased Survival Of Idiopathic Pulmonary Fibrosis Patients With Heat Shock Protein 70 Autoreactivity.  Am. J. Respir. Crit. Care Med., May 2011; 183: A4275.
48. Noth I, Zhang Y, Barber M, Gibson KF, Ma S-F, Lindell KO, Kaminski N, Hysi P, Nicolae D, and. Garcia JN.  Genome Wide Association Study In Idiopathic Pulmonary Fibrosis Identifies LCLAT1 As A Novel Candidate Gene.  Am. J. Respir. Crit. Care Med., May 2011; 183: A2266.
49. Pagnotta EB, MacPherson MF, Gibson KF, Kaminski N, Lindell KO. Does The Oxygen Prescription Match The Study Results?: A Prospective Study Of Patients In A Speciality Interstitial Lung Disease Center. Am J Respir Crit Care Med 185;2012:A1490
50. Juan Guardela B, Herazo J, Tedrow JR, Chensny L, Richards T, Spira A, Correll M, Quackenbush J, Geraci M, Schwartz DA, Sciurba FC, Gibson KF, Pandit K, Kaminski N. The Expression Of Long Intergenic Noncoding RNAs In Idiopathic Pulmonary Fibrosis And Their Possible Role As Suppressors Of Proliferation. Am J Respir Crit Care Med 185;2012:A3507
51. Richards T, Kass D, Lindell KO, Kaminski N, Gibson KF. Gender Effects On Pre- And Post-Transplant Survival In Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 185;2012:A3766
52. Yu G, Tedrow J, Rabinovich EI, Drigo R, Gibson KF, Yousem S, Richards T, Chensny L, Bianco A, Kaminski N. Role Of DIO2 In Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 185;2012:A4932
53. Vuga L, Milosevic J, Pandit K, Ben-Yehudah A, Richards T, Choi J, Sciurba J, Zhang Y, Myerburg M. Parwani A, Gibson KF, Kaminski N. Cartilage Oligomeric Matrix Protein Is Upregulated And Modulates TGF-β Signaling In Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 185;2012:A5560
54. Bauer Y, Gibson KF, Guardela B, Hess P, Klenk A, Lindell KO, Renault B, Rey M, Tedrow JR, Weber E, Kaminski N, Nayler O. Translational Value Of The Bleomycin Rat Model For The Treatment Of Patients With Idiopathic Pulmonary Fibrosis (IPF). Am J Respir Crit Care Med 185;2012:A6241

Patents:

Gene Expression Profiles for IPF Pulmonary Fibrosis; US Provisional Patent Application No. 61/561, 543 filed November 18, 2011; and PCT Application No. PCT/US2012/065540 filed November 16, 2012.

Seminars And Invited Lectureships:

1. 1990       Visiting Professor.  Division of Pulmonary and Critical Care Medicine, Boston University school of Medicine.  Research Seminar:  Characterization of a lamellar body fraction that is free of lysosomal constituents.
2. 1990       Visiting Professor.  Institute for Environmental Medicine-University of Pennsylvania.  Research seminar: Lysosomes and lamellar bodies in alveolar type II cells.
3. 1991       Research seminar, “Surfactant metabolism by type II cells”.  Department of Pediatrics, Division of Neonatology, Magee-Womens Hospital, Pittsburgh, PA.         
4. 1994       Research seminar, “Surfactant metabolism by alveolar type II pneumocytes”. Pittsburgh Cardiovascular Research Society and Department of Cell Biology and Physiology. University of Pittsburgh.
5. 1995       Visiting Professor. University of Iowa, School of Medicine – Division of Pulmonary, Occupational, and Critical Care Medicine.
6. 1996       “Diagnosis and Management of Embolus and DVT”, Lecture to University of Pittsburgh School of Nursing, Acute Care NP students  January 6, 2004.
7. 2004    Lecture to Department of Medicine, University of Pittsburgh, School of Medicine “The      Pneumoconiosis” January 14, 2004
8. 2004       “Interstitial Lung Disease: Clinical” Lecture to Molecular Pathobiology students at University of Pittsburgh for the Lung Module of the Molecular Pathobiology Course (MSCMP 2740).
9. 2004    “Clinical Overview of the Interstitial Lung Diseases” Lecture for Pulmonary Course, Advances in Pulmonary Medicine, University of Pittsburgh, June 5, 2004
10. 2004    Lecture for Pulmonary, Allergy & Critical Care Medicine Bench Research Summer Course July 12-16, 2004.  “Laser Capture Microdissection”
11. 2004       “Bioinformatics of IPF” 7th Workshop of Molecular and Cellular Mechanism of Interstitial Pneumonia, Tokyo, Japan August 21-22, 2004
12. 2004       “Functional Genomics in Interstitial Lung Disease” Medical Grand Rounds, Tohoku University, Sendai, Japan  August 23, 2004
13. 2004       “Sarcoidosis” Keynote speaker for the Allegheny Tobacco Free Conference, Sheraton Station Square, October 27, 2004
14. 2004       “Idiopathic Pulmonary Fibrosis” Medical Grand Rounds, UPMC- Shadyside November 11, 2004.
15. 2005       Lecture for Pulmonary, Allergy & Critical Care Medicine Grand Rounds “Sarcoidosis: State of the Art and Science” January 14 , 2005
16. 2005       “Interstitial Lung Disease”, Lecture to University of   Pittsburgh, Department of Medicine UPMC-Montefiore, March 9, 2005
17. 2005       “Sarcoidosis:  Diagnosis and Management” Medical Grand Rounds, UPMC - Shadyside     Hospital, April 8, 2005
18. 2005   “Sarcoidosis: State of the Art & Science” Speaker at Annual PTS Scientific Sessions Conference, Sheraton University City Hotel, Philadelphia, PA September 24, 2005
19. 2006       “Diagnosis and Management of Embolus and DVT”    Lecture to University of Pittsburgh School of Nursing, Acute Care NP students January 10, 2006.
20. 2006       “Sarcoidosis” Children’s Hospital of Pittsburgh, Allergy / Immunology Conference Speaker, January 17, 2006
21. 2006       "Sarcoidosis - Unmet Challenges in Research and Treatment" Pulmonary, Allergy & Critical Care Medicine Grand Rounds, March 24, 2006
22. 2007       “Pulmonary Thromboembolism" Lecture to University of Pittsburgh School of Nursing, Acute Care NP students, January 3, 2007
23. 2007       “Occupational Lung Disease” Lecture to physicians, residents, fellows at UPMC-Shadyside Hospital, January 10, 2007.
24. 2007       Pathobiology lecture Lecture to students West Biomedical Science Tower, January 25, 2007   “Interstitial Lung Disease”. Lecture to chief residents at UPMC Montefiore, January 31, 2007.
25. 2007   “Importance of Oxygen” Lecture to IPF Support Group, UPMC-Presbyterian, February 5, 2007.
26. 2007    ”IPF and Pirfenidone”  Lecture to pulmonary, MDs, fellows and heath care professionals on Isabella Restaurant, Mt. Washington, Pittsburgh, PA, February 5, 2007.
27. 2007       “Interstitial Lung Disease”.Lecture to VAMC medical house staff training  program, February 7, 2007 
28. 2007       “Sarcoidosis: revealed”  Lecture to Graduate School of Public Health, Minority Student Organization and Association of Women in Public Health,  University of Pittsburgh, March 1, 2007.
29. 2007       “Interstitial Lung Disease: Pitfalls in Diagnosis”  Advanced Lung Disease Course, University of Pittsburgh, PACCM and Center for Continuing Education in the Health Sciences at Marriott City Center, Pittsburgh, PA, March 24-25, 2007.
30. 2007       European Respiratory Society Lecture in Stockholm, Sweden, September 14, 2007.
31. 2007   “Scarring Lung Disease:  The Idiopathic Interstitial Pneumonias"   Medical Grand Rounds, Albany Medical Center, Albany, NY April 12, 2007
32. 2007   "Hypersensitivity Pneumonitis: pathogenesis and disease management." lecture to  Pittsburgh Poison Center, December 14, 2007.
33. 2008  “Diagnosis and Management of Pulmonary Embolus and DVT” University of Pittsburgh School of Nursing, Acute Care NP students, January  8, 2008.
34. 2009       "Diagnosis and Management of Pulmonary Embolus” University of Pittsburgh School of Nursing, Acute Care NP students, February 3, 2009.
35. 2009       “The Importance of Supplemental Oxygen Therapy” IPF Support Group, UPMC-Presbyterian, April 6, 2009
36. 2009       “Diagnosis and Management of the Patient with Interstitial Lung Disease” Lecture to University of Pittsburgh School of Nursing, Acute Care NP students, September 23, 2009
37. 2009    “Restrictive Lung Disease” American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), David L. Lawrence Convention Center, Pittsburgh, PA, October 1, 2009
38. 2009 “Pulmonary Fibrosis” Klingensmith Health Care Respiratory & Sleep Symposium, Mars, PA., October 30, 2009.
39. 2010       “Sarcoidosis: State of the Art and Science” Medical Grand Rounds, UPMC Shadyside Hospital, February 4, 2010.
40. 2010       Diagnosis and Management of the Patient with Interstitial Lung Disease”, Lecture to University of Pittsburgh School of Nursing, Acute Care NP students September 22, 2010
41. 2010       “Update in Internal Medicine 2010 – Lung Disease.”  Lecture at the Mid-Level Practitioners Seminar. October 12, 2010
42. 2011       “Diagnosis and Management of Pulmonary Embolus and DVT” Lecture to students in Acute Care Nurse Practitioner Area of concentration at the University of Pittsburgh School of Nursing, February 8, 2011
43. 2011       “Interstitial Lung Disease” Pulmonary Series Lecture to Housestaff, VA Hospital, February 10, 2011.
44. 2011       “Interstitial Lung Disease” Pulmonary Series Lecture to Housestaff, UPMC Montefiore Hospital, February 17, 2011.
45. 2011   “Emerging Concepts in Diffuse Parenchymal Lung Diseases” Medical Grand Rounds, UPMC Mercy Hospital, February 24, 2011
46. 2011       “Interstitial Lung Disease” Clinical Presentation, Module 5 of MSCMP 2740 Molecular Pathobiology Spring Course, March 22, 2011
47. 2011       Lecture for Pulmonary, Allergy & Critical Care Medicine Bench Research Summer Course July 8, 2011. “Laser Microdissection Techniques”
48. 2011       “ Diagnosis and Management of the Patient with Interstitial Lung Disease” Lecture to University of Pittsburgh School of Nursing, Acute Care NP students, September 21, 2011
49. 2012       “Sarcoidosis – State of the Art and Science” Pulmonary Grand Rounds, Pulmonary, Allergy and Critical Care Medicine, February 24, 2012
50. 2012       “Diagnosis and Management of Pulmonary Embolus/DVT” Lecture to the University of Pittsburgh School of Nursing, Acute Care NP students, March 13, 2012.
51. 2012       “Idiopathic Pulmonary Fibrosis” Lecture to Molecular Pathobiology students at University of Pittsburgh for the Lung Module of the Molecular Pathobiology Course.
52. 2013       “Diagnosis and Management of the Patient with Interstitial Lung Disease” Lecture to the University of Pittsburgh School of Nursing, Acute Care NP students, March 5, 2013.
53. 2013     Fundamentals of Bench Research, “Laser Microdissection Techniques” June 30, 2013.
54. 2013       “Diagnosis and Management of the Patient with Interstitial Lung Disease” Lecture to the University of Pittsburgh School of Nursing, Acute Care NP students, September 18, 2013.
55. 2014         “Diagnosis and Management of the Patient with Interstitial Lung Disease” Lecture to the University of Pittsburgh School of Nursing, Acute Care NP students, September 10, 2014.